Insider Trading History of Gould Robert J

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) of Gould Robert J since 2014. This trader's CIK number is 1577034. At the time of last reporting, Gould Robert J was the Interim President & CEO of Fulcrum Therapeutics, Inc.. (stock ticker symbol FULC). Also see all insider trading activities at Fulcrum Therapeutics, Inc..

Note that in the past Gould Robert J also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at Fulcrum Therapeutics, Inc. (FULC) by Gould Robert J

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2023 FULC 0 $0 6,766 $101,490 0 $0
2022 FULC 0 $0 237,939 $3,522,611 237,939 $1,865,437
2021 FULC 0 $0 28,215 $360,517 0 $0
2020 FULC 0 $0 22,500 $452,954 0 $0

Yearly summary of insider trading at Epizyme, Inc. (EPZM) by Gould Robert J

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2015 EPZM 0 $0 212,108 $4,483,670 212,108 $108,174
2014 EPZM 0 $0 330,000 $8,750,370 330,000 $164,400


Insider trading activities at 2 companies by Gould Robert J:

1. Fulcrum Therapeutics, Inc. (FULC)

2. Epizyme, Inc. (EPZM)

Table 1. Insider trading of Fulcrum Therapeutics, Inc. (FULC) by Gould Robert J

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2023-01-13 FULC Sale 6,766 15.00 101,490
2022-06-07 FULC Option Ex 71,435 7.84 560,050
2022-06-07 FULC Sale 71,435 8.09 577,909
2022-06-03 FULC Sale 25,551 7.95 203,053
2022-06-02 FULC Sale 16,689 7.92 132,160
2022-06-03 FULC Option Ex 25,551 7.84 200,319
2022-06-02 FULC Option Ex 16,689 7.84 130,841
2022-06-06 FULC Sale 24,382 8.10 197,591
2022-06-06 FULC Option Ex 24,382 7.84 191,154
2022-04-07 FULC Option Ex 5,631 7.84 44,147
2022-04-07 FULC Sale 5,631 24.02 135,228
2022-04-05 FULC Sale 52,552 24.26 1,274,753
2022-04-04 FULC Sale 7,235 24.02 173,748
2022-04-05 FULC Option Ex 52,552 7.84 412,007
2022-04-04 FULC Option Ex 7,235 7.84 56,722
2022-04-01 FULC Sale 34,464 24.03 828,169
2022-04-01 FULC Option Ex 34,464 7.84 270,197
2021-03-15 FULC Sale 9,211 12.13 111,775
2021-03-16 FULC Sale 789 12.43 9,805
2021-02-16 FULC Sale 8,215 14.38 118,107
2021-01-20 FULC Sale 10,000 12.08 120,830
2020-07-08 FULC Sale 2,500 20.00 50,000
2020-06-25 FULC Sale 2,500 20.80 51,992
2020-06-09 FULC Sale 156 20.00 3,120
2020-06-05 FULC Sale 3,433 20.17 69,250
2020-06-03 FULC Sale 1,500 20.13 30,192
2020-06-04 FULC Sale 1,300 20.05 26,058
2020-06-01 FULC Sale 5 20.00 100
2020-06-02 FULC Sale 2,797 20.00 55,940
2020-05-28 FULC Sale 1,919 20.01 38,391
2020-05-29 FULC Sale 1,390 20.08 27,911
2020-05-26 FULC Sale 2,500 20.00 50,000
2020-02-19 FULC Sale 2,500 20.00 50,000

Table 2. Insider trading of Epizyme, Inc. (EPZM) by Gould Robert J

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2015-12-29 EPZM Option Ex 20,303 .51 10,354
2015-12-30 EPZM Option Ex 11,805 .51 6,020
2015-12-29 EPZM Sale 20,303 18.01 365,616
2015-12-30 EPZM Sale 11,805 18.02 212,714
2015-09-08 EPZM Option Ex 60,000 .51 30,600
2015-09-08 EPZM Sale 60,000 19.56 1,173,600
2015-08-03 EPZM Sale 60,000 22.17 1,330,200
2015-08-03 EPZM Option Ex 60,000 .51 30,600
2015-07-06 EPZM Option Ex 60,000 .51 30,600
2015-07-06 EPZM Sale 60,000 23.36 1,401,540
2014-11-03 EPZM Option Ex 30,000 .51 15,300
2014-11-03 EPZM Sale 30,000 25.62 768,510
2014-10-01 EPZM Sale 30,000 26.66 799,860
2014-10-01 EPZM Option Ex 30,000 .51 15,300
2014-09-02 EPZM Sale 30,000 33.60 1,007,940
2014-09-02 EPZM Option Ex 30,000 .51 15,300
2014-08-01 EPZM Option Ex 30,000 .51 15,300
2014-08-01 EPZM Sale 30,000 30.37 911,190
2014-07-01 EPZM Option Ex 30,000 .51 15,300
2014-07-01 EPZM Sale 30,000 31.71 951,180
2014-06-02 EPZM Option Ex 30,000 .51 15,300
2014-06-02 EPZM Sale 30,000 22.75 682,440
2014-05-01 EPZM Sale 30,000 22.08 662,520
2014-05-01 EPZM Option Ex 30,000 .51 15,300
2014-04-07 EPZM Option Ex 30,000 .51 15,300
2014-04-07 EPZM Sale 30,000 20.23 606,750
2014-02-10 EPZM Option Ex 60,000 .51 30,600
2014-02-10 EPZM Sale 60,000 29.25 1,755,000
2014-01-02 EPZM Option Ex 30,000 .38 11,400
2014-01-02 EPZM Sale 30,000 20.17 604,980

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Gould Robert J (Interim President & CEO of Fulcrum Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.